openPR Logo
Press release

Malaysia Intravenous Immunoglobulin (IVIG) Market to Play Major Role in $18,649 thousand Economic Boost

10-12-2020 04:14 PM CET | Health & Medicine

Press release from: Allied Market Research

Malaysia Intravenous Immunoglobulin (IVIG) Market

Malaysia Intravenous Immunoglobulin (IVIG) Market

UPDATE AVAILABLE ON-DEMAND

According to the report by Allied Market Research, the Malaysia IVIG market is estimated to register a CAGR of 6.1% from 2016 to 2022. The research helps leading players and startups to devise new strategies based on current market trends and changing dynamics. Competitive landscape is mentioned in the report based on business segments, products portfolio, and strategic moves & developments of leading market players. Detailed segmentation assists in determining growing segments and determining further steps to capitalize on lucrative segments. Regional landscape is helpful in determining opportunities and driving factors of each region and taking further steps.

The scope of applications of IVIG has widened, as it is used to treat various neurological, hematological, dermatological, and immune deficiency disorders, with the help of improved clinical practices and advanced technologies.

To Get the Sample Copy of Report Visit @ https://www.alliedmarketresearch.com/request-sample/2281

The IVIG products gained significant attention in the recent years due to their high efficacy in the treatment of immune diseases. Prevalence of various antibody deficiency disorders such as common variable immune deficiency (CVID), specific antibody deficiency, and hypogammaglobulinemia, increase in IVIG indications, improved production & purification processes, growth in awareness towards antibody deficiency, and rare immune disorders among patient population drive the growth of the IVIG market.

However, high costs associated with the IVIG treatment; shortage of IVIG; and side effects of IVIG treatment such as headache, migraine, fever, nausea or vomiting, and cough hinder the market growth. IVIG products are widely used for the treatment of immunodeficiency disease, ITP, chronic lymphocytic leukemia (CLL), Kawasaki disease, and others. The untapped potential of Malaysia as an emerging market and development of cost-effective therapeutics through large-scale production act as opportunities to the market players in this region.

Inquire Before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2281

Hypogammaglobulinemia and CIDP held dominant market shares in 2015 due to the large patient population and unavailability of effective alternatives to IVIG treatment. Based on product type, the market is segmented into immunoglobulin G (IgG), IgA, IgM, IgE, and IgD. On the basis of concentration, it is categorized into 5%, 10%, and others. By mode of delivery, it is bifurcated into intravenous, subcutaneous, and intramuscular mode of delivery. The intravenous mode of delivery segment held the largest revenue in 2015 and is anticipated to continue this trend during the forecast period. High bioavailability of immunoglobulins and rapid absorption rate offered by intravenous mode of delivery are the factors that supplement the growth of the intravenous mode of delivery IVIG market.

The Major key companies profiled Are:

Grifols S.A., Octapharma AG, Green Cross Corporation, Baxalta (Shire), Bio Products Laboratory Ltd., Biotest AG, CSL Behring, Omrix Biopharmaceuticals Ltd., Bayer Healthcare, and Baxter International Inc.

Access Full Report @ https://www.alliedmarketresearch.com/malaysia-intravenous-immunoglobulin-ivig-market

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malaysia Intravenous Immunoglobulin (IVIG) Market to Play Major Role in $18,649 thousand Economic Boost here

News-ID: 2156146 • Views:

More Releases from Allied Market Research

Cristobalite Market Insights, Size, Share, Overview And Growth Report 2031
Cristobalite Market Insights, Size, Share, Overview And Growth Report 2031
According to the report from Allied Market Research, the global cristobalite market reached $36.3 million in 2021, with an estimated growth to $56.6 million by 2031, displaying a CAGR of 4.6% from 2022 to 2031. This report offers an in-depth analysis of market dynamics, major segments, value chain, competitive landscape, and regional trends, providing valuable insights for stakeholders to develop sustainable strategies and gain a competitive edge. Cristobalite, a mineral polymorph
Glycol Ethers Global Market Report 2021 - By Growth, Trends, Size, Share, Forecast To 2030
Glycol Ethers Global Market Report 2021 - By Growth, Trends, Size, Share, Foreca …
Allied Market Research has released a report titled "Glycol Ethers Market by Type (E-series and P-series), Application (Solvent, Anti-icing, Hydraulic and Brake Fluid, and Chemical Intermediates), End Use (Paints & Coatings, Printing, Pharmaceuticals, Cosmetics & Personal Care, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the global glycol ethers industry was valued at $6.5 billion in 2020 and is projected to reach $11.5 billion by
Pain Management Drugs Market Size, Share, Trends, Growth, and Revenue Projections by 2030
Pain Management Drugs Market Size, Share, Trends, Growth, and Revenue Projection …
According to the report, the global Pain Management Drugs Market size was estimated at USD 71.43 billion in 2019, and is anticipated to hit USD 91.64 billion by 2027, registering a CAGR of 3.8% from 2020 to 2027. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-for-customization/404?reqfor=covid 𝐃𝐫𝐢𝐯𝐞𝐫𝐬, 𝐫𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬, 𝐚𝐧𝐝 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬- Increase in prevalence of chronic diseases, favorable regulatory scenario, and surge in the number of geriatric population drive the growth of the global
Ceramic Injection Molding Market is projected to reach $746.2 million in 2026, growing at a CAGR of 8.8%
Ceramic Injection Molding Market is projected to reach $746.2 million in 2026, g …
global ceramic injection molding market was valued at $375.0 million in 2018 and is expected to reach $746.2 million by 2026, growing at a CAGR of 8.8%. Ceramic injection molding (CIM) is a subset of the powder injection molding (PIM) process used for mass-producing intricate ceramic parts. This technology enables the production of precision components with complex geometries, including bearings, sockets, dental implants, mobile phone buttons, and laptop keypads, with

All 5 Releases


More Releases for IVIG

Intravenous Immunoglobulin (IVIg) Market Report 2018: Segmentation by Product (I …
Global Intravenous Immunoglobulin (IVIg) market research report provides company profile for Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Global Intravenous Immunoglobulin (IVIG) Market Analysis and Forecast Prediction …
Market Research Report Search Engine (MRRSE) recently announced the addition of a new research study to its comprehensive collection of research reports. The research report, titled “Intravenous Immunoglobulin (IVIG) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024” offers a detailed analysis of the market, providing insights into the market dynamics that are expected to influence the overall market positively in the next few years.
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise …
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research
04-10-2017 | Health & Medicine
TMR
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are …
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support market’s growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across the
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from